Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer

被引：1

作者：

Yamaguchi, Teppei ^{[1
]}

Hida, Toyoaki ^{[1
]}

机构：

[1] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan

来源：

TRANSLATIONAL CANCER RESEARCH | 2019年 / 8卷 / 08期

关键词：

PHASE-III; MAINTENANCE BEVACIZUMAB; CHEMOTHERAPY; COMBINATION; NIVOLUMAB; DOCETAXEL; EFFICACY; THERAPY; SAFETY;

D O I：

10.21037/tcr.2019.12.57

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E11 / E14

页数：4

共 20 条

[1] Effect of renal function on pemetrexed-induced haematotoxicity [J].

Ando, Yosuke ;

Hayashi, Takahiro ;

Ujita, Moeko ;

Murai, Sumie ;

Ohta, Hideki ;

Ito, Kaori ;

Yamaguchi, Teppei ;

Funatsu, Minori ;

Ikeda, Yoshiaki ;

Imaizumi, Kazuyoshi ;

Kawada, Kenji ;

Yasuda, Kimio ;

Yamada, Shigeki .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (01) :183-189

[2]

[Anonymous], 2019, Ann Oncol, DOI DOI 10.1093/ANNONC/MDZ394

[3] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[4] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].

Brahmer, Julie ;

Reckamp, Karen L. ;

Baas, Paul ;

Crino, Lucio ;

Eberhardt, Wilfried E. E. ;

Poddubskaya, Elena ;

Antonia, Scott ;

Pluzanski, Adam ;

Vokes, Everett E. ;

Holgado, Esther ;

Waterhouse, David ;

Ready, Neal ;

Gainor, Justin ;

Aren Frontera, Osvaldo ;

Havel, Libor ;

Steins, Martin ;

Garassino, Marina C. ;

Aerts, Joachim G. ;

Domine, Manuel ;

Paz-Ares, Luis ;

Reck, Martin ;

Baudelet, Christine ;

Harbison, Christopher T. ;

Lestini, Brian ;

Spigel, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135

[5] Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer [J].

Gandhi, L. ;

Rodriguez-Abreu, D. ;

Gadgeel, S. ;

Esteban, E. ;

Felip, E. ;

De Angelis, F. ;

Domine, M. ;

Clingan, P. ;

Hochmair, M. J. ;

Powell, S. F. ;

Cheng, S. Y. -S. ;

Bischoff, H. G. ;

Peled, N. ;

Grossi, F. ;

Jennens, R. R. ;

Reck, M. ;

Hui, R. ;

Garon, E. B. ;

Boyer, M. ;

Rubio-Viqueira, B. ;

Novello, S. ;

Kurata, T. ;

Gray, J. E. ;

Vida, J. ;

Wei, Z. ;

Yang, J. ;

Raftopoulos, H. ;

Pietanza, M. C. ;

Garassino, M. C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2078-2092

[6]

Kawate S, 2006, WORLD J GASTROENTERO, V12, P5237

[7] Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment [J].

Langer, Corey J. ;

Hirsh, Vera ;

Ko, Amy ;

Renschler, Markus F. ;

Socinski, Mark A. .

CLINICAL LUNG CANCER, 2015, 16 (02) :112-120

[8] Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function [J].

Mita, AC ;

Sweeney, CJ ;

Baker, SD ;

Goetz, A ;

Hammond, LA ;

Patnaik, A ;

Tolcher, AW ;

Villalona-Calero, M ;

Sandler, A ;

Chaudhuri, T ;

Molpus, K ;

Latz, JE ;

Simms, L ;

Chaudhary, AK ;

Johnson, RD ;

Rowinsky, EK ;

Takimoto, CH .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) :552-562

[9] Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial [J].

Mok, Tony S. K. ;

Wu, Yi-Long ;

Kudaba, Iveta ;

Kowalski, Dariusz M. ;

Cho, Byoung Chul ;

Turna, Hande Z. ;

Castro, Gilberto, Jr. ;

Srimuninnimit, Vichien ;

Laktionov, Konstantin K. ;

Bondarenko, Igor ;

Kubota, Kaoru ;

Lubiniecki, Gregory M. ;

Zhang, Jin ;

Kush, Debra ;

Lopes, Gilberto .

LANCET, 2019, 393 (10183) :1819-1830

[10] PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer [J].

Patel, Jyoti D. ;

Socinski, Mark A. ;

Garon, Edward B. ;

Reynolds, Craig H. ;

Spigel, David R. ;

Olsen, Mark R. ;

Hermann, Robert C. ;

Jotte, Robert M. ;

Beck, Thaddeus ;

Richards, Donald A. ;

Guba, Susan C. ;

Liu, Jingyi ;

Frimodt-Moller, Bente ;

John, William J. ;

Obasaju, Coleman K. ;

Pennella, Eduardo J. ;

Bonomi, Philip ;

Govindan, Ramaswamy .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) :4349-U77

← 1 2 →